Skip to content

Use of dexmedetomidine for pain relief after cesarean section.

Effect of dexmedetomidine as an adjuvant in quadratus lumborum block in patients undergoing cesarean section â?? A randomised control study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021394
Enrollment
37
Registered
2019-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Quadratus Lumborum block for post opertive pain relief in cesaren section.: QL block using 30 mL 0.25% injection Bupivacaine with inj. dexmedetomidine 1 mcg/kg. Intervention2: Quadratus

Sponsors

All India Institute of Medical Sciences Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA II females with normal singleton pregnancies with a gestation of >= 37 weeks, and scheduled for Caesarean Section under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1. High risk pregnancies and acute emergencies 2. Patients whose height 3. Patients with known allergy to study drugs (bupivacaine and dexmedetomidine) 4. Patients with contraindications to spinal anaesthesia.

Design outcomes

Primary

MeasureTime frame
To compare the time to the first request of rescue analgesia during postoperative period among the two groups receiving QL blocks with or without dexmedetomidine in first 24 hrs.Timepoint: To compare the time to the first request of rescue analgesia during first 24 hrs of postoperative period among the two groups receiving QL blocks with or without dexmedetomidine.

Secondary

MeasureTime frame
To compare the number of doses of rescue analgesia, Numeric rating scale (NRS)for pain, Ramsay sedation score and patient satisfaction in first 24 hr.Timepoint: first 24 hr post operative period.

Countries

India

Contacts

Public ContactDr Vishnu Anandan

All India Institute of Medical Sciences, Bhubaneswar

anaes_neha@aiimsbhubaneswar.edu.in9438884045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026